ARCHIVES

FDA, Companies Fail To Collect COI Forms, Report Says

This article is from The Cancer Letter archive.

Vol. 35 No. 02 | January 16, 2009

Download PDF Visit The Full Archive

Related Articles

Drug Development Gets Extra $500,000

November 18, 1977

ODAC Member Critical Of Amgen For Price Incentives.

March 21, 2008

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

September 26, 2008

In Brief: Reagan Okays Reauthorization; Harold Freeman ACS President, Robert Schweitzer President Elect

November 11, 1988

A Texas Radiation Center’s Survival Move Draws M.D. Anderson Into PPM Competition

February 27, 1998